Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro.
D016604:Aflatoxin B1 / Q000031:analogs & derivatives; D000348:Aflatoxins / Q000031:analogs & derivatives / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D002273:Carcinogens / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D004247:DNA / Q000378:metabolism; D004988:Ethers, Cyclic / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D008738:Methyl Ethers; D008745:Methylation; D008862:Microsomes, Liver / Q000378:metabolism; D008875:Middle Aged; D012335:RNA, Ribosomal / Q000378:metabolism; D051381:Rats; D014316:Tritium
D000348:Aflatoxins; D002273:Carcinogens; D004988:Ethers, Cyclic; D008738:Methyl Ethers; D012335:RNA, Ribosomal; D014316:Tritium; C006426:aflatoxin B1-2,3-oxide; D004247:DNA; D016604:Aflatoxin B1